Aprea Therapeutics, Inc. (APRE) Earnings
|
Expand Research on APRE
| Next EPS Date | 8/12/26 *Est. | EPS Growth Rate | +66.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | 0.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/13/26 | Q126 | -$0.22 | $0.00 | -$0.22 | N/A | N/A | N/A |  | | Details | |
3/16/26  |
Q425 | -$0.32 | $0.00 | -$0.32 | $3.34M | N/A | N/A | | | Details | |
| 11/12/25 | Q325 | -$0.47 | $0.00 | -$0.47 | $1.84M | N/A | N/A | | | Details | |
| 8/12/25 |
Q225 | N/A | -$0.26 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.53 | $0.00 | -$0.53 | N/A | N/A | N/A | | | Details | |
| 5/14/25 | Q125 | -$0.66 | $0.00 | -$0.66 | N/A | N/A | N/A | | | Details | |
| 3/25/25 | Q424 | -$0.49 | $0.00 | -$0.49 | $210K | N/A | N/A | | | Details | |
| 5/17/23 | Q123 | N/A | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A |
